LISTED biotechnology company Meditech has secured funding from Danish-based biotechnology company Novozymes to pursue phase two clinical trials of its anti-cancer treatment, HyCAMP.
13/01/2004 - 21:00
Meditech gets foreign backing for cancer test
13/01/2004 - 21:00
